Monday, November 4, 2019

Myriad Genetics EPS misses by $0.23, misses on revenue

Myriad Genetics (NASDAQ:MYGN): Q1 Non-GAAP EPS of $0.08 misses by $0.23; GAAP EPS of -$0.28 misses by $0.29.
Revenue of $186.3M (-7.9% Y/Y) misses by $16.04M.
Shares -18.52%.
Press Release
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.